Delivery Order SPE2DB22D2007-SPE2DB24FJ3YV
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, with a ceiling value of $19,999.44, is for the provision of the pharmaceutical product PADCEV 30 MG VIALS to the Defense Logistics Agency (DLA). The contract is a Delivery Order issued under the company's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,999.72 firm fixed-price delivery order is for the supply of PADCEV 30 MG vials, a pharmaceutical product. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical....
- The U.S. Department of Defense (DoD) Defense Logistics Agency (DLA) awarded a $24,999.30 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of PADCEV 30 MG vials, a pharmaceutical product, with a period of performance through October 28, 2024. AmerisourceBergen is a large pharmaceutical distributor that provides a wide range of medical commodities to federal agencies, including the military. This contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,345.32, is for the delivery of PADCEV 30 MG vials. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 30, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award, valued at $2,771.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for PADCEV 30 MG VIALS, with a firm fixed price and an ultimate completion date of March 25, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was made by the Defense Logistics Agency (DLA) on June 25, 2024. The $41,647.50 firm fixed-price delivery order is for the supply of PADCEV 30 MG vials, with a completion date of July 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,175.20 Firm Fixed Price Delivery Order contract is for the supply of PADCEV 30 MG VIALS, a medical product, with a completion date of February 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $116,823.84, is for the delivery of PADCEV 30 MG VIALS, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is also...
- This federal contract award is for the supply of Padcev 30 mg vials by Amerisourcebergen Drug Corp's Corporate Office Division to the Defense Logistics Agency (DLA). The $24,999.30 firm fixed price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,345.32, is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ3YVDelivery Order
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at up to $14,999.58, is for the delivery of 4565092788 PADCEV 30 MG VIALS. This is a firm fixed-price delivery order contract with a completion date of July 29, 2024. Amerisourcebergen is a major pharmaceutical distribution company that has received numerous federal contract awards to supply a wide range of prescription medications, over-the-counter drugs, and medical supplies to various government agencies, particularly the Department of Defense and Veterans Affairs healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.0k | 7/8/24 |